Corpus 1,280 assessed · 1,181 scored · 646 reproduced ≥75 · 170 flagged ·∅ 74/100

Publications 4 Datasets 392.5k Experiments 5.2k

Explore

Filters: medium ✕ Immunology ✕ Reproducible only ✕ clear all

4 matching publication(s)

Publication	Journal	Year	Score	Verdict
COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis. PMID 35870428	EBioMedicine	2022	85	L1 85/100
Mural cell-derived chemokines provide a protective niche to safeguard vascular macrophages and limit chronic inflammation. PMID 37652021	Immunity	2023	83	L1 83/100
Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic l PMID 37217248	J Immunother Cancer	2023	76	L1 76/100
The liver as an immunological barrier redefined by single-cell analysis. PMID 32176810	Immunology	2020	100	L1 100/100

COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis.

PMID 35870428 · EBioMedicine · 2022

L1 85/100

Mural cell-derived chemokines provide a protective niche to safeguard vascular macrophages and limit chronic inflammation.

PMID 37652021 · Immunity · 2023

L1 83/100

Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic l

PMID 37217248 · J Immunother Cancer · 2023

L1 76/100

The liver as an immunological barrier redefined by single-cell analysis.

PMID 32176810 · Immunology · 2020

L1 100/100